Cite
Ongaro E, Cremolini C, Rossini D, et al. Clinical and molecular determinants of extrahepatic disease progression in patients with metastatic colorectal cancer with liver-limited metastases deemed initially unresectable. ESMO Open. 2019;4(2):e000496doi: 10.1136/esmoopen-2019-000496.
Ongaro, E., Cremolini, C., Rossini, D., Corti, F., Pagani, F., Morelli, L., Urbani, L., Masi, G., Sposito, C., Filippi, B., Borelli, B., Zucchelli, G., Moretto, R., Boccaccino, A., Solaini, L., de Braud, F., Mazzaferro, V., Falcone, A., Cucchetti, A., & Pietrantonio, F. (2019). Clinical and molecular determinants of extrahepatic disease progression in patients with metastatic colorectal cancer with liver-limited metastases deemed initially unresectable. ESMO open, 4(2), e000496. https://doi.org/10.1136/esmoopen-2019-000496
Ongaro, Elena, et al. "Clinical and molecular determinants of extrahepatic disease progression in patients with metastatic colorectal cancer with liver-limited metastases deemed initially unresectable." ESMO open vol. 4,2 (2019): e000496. doi: https://doi.org/10.1136/esmoopen-2019-000496
Ongaro E, Cremolini C, Rossini D, Corti F, Pagani F, Morelli L, Urbani L, Masi G, Sposito C, Filippi B, Borelli B, Zucchelli G, Moretto R, Boccaccino A, Solaini L, de Braud F, Mazzaferro V, Falcone A, Cucchetti A, Pietrantonio F. Clinical and molecular determinants of extrahepatic disease progression in patients with metastatic colorectal cancer with liver-limited metastases deemed initially unresectable. ESMO Open. 2019 May 09;4(2):e000496. doi: 10.1136/esmoopen-2019-000496. eCollection 2019. PMID: 31231562; PMCID: PMC6555604.
Copy
Download .nbib